Suppr超能文献

迈向高效稳定的益生菌。

Towards effective and stable probiotics.

作者信息

Yarullina D R, Damshkaln L G, Bruslik N L, Konovalova O A, Ilinskaya O N, Lozinsky V I

机构信息

Department of Microbiology, Kazan (Volga Region) Federal University, Kazan, Russia.

Institute of Element-Organic Compounds, Russian Academy of Sciences, Moscow, Russia.

出版信息

Int J Risk Saf Med. 2015;27 Suppl 1:S65-6. doi: 10.3233/JRS-150692.

Abstract

BACKGROUND

Probiotics are live microorganisms, generally either lactobacilli or bifidobacteria, which when administered in adequate amounts confer a health benefit to the host [1]. Due to the growing evidence of health benefits associated with their use, probiotics are of increasing interest and represent now a significant growth area in the functional foods industry [2]. However, to be effective, orally administered probiotics should survive preparation of dosage forms and passage through acidic environment of the gastrointestinal tract (GIT). Reaching the intestine, these microorganisms should be able to establish themselves, remain viable and perform their beneficial actions. In this context, oral formulations have to protect probiotic bacteria from gastric acidity and delay their release in the small intestine in order to allow their complete release in the colon.

OBJECTIVE

To evaluate effects of starch formulations of lactobacilli on their survival in gastric environment and probiotic properties.

METHODS

Nineteen Lactobacillus strains belonging to the species L. fermentum (14 strains), L. plantarum (4 strains), and L. rhamnosus (1 strain), were isolated from dairy products and probiotics, and were used in this study. Lactobacilli were cultured in de Man, Rogosa, Sharpe (MRS) broth (Merck, Germany) under microaerobic conditions at 37°C.Amylolytic activity of lactobacilli, cultured for 3-5 days on MRS agar supplemented with 1% soluble potato starch (SPS), was determined with iodine reagent (0.01 M I2-KI solution).Loading in starch was performed with L. plantarum 8PA3 bacteria ("Dry lactobacterin", Perm, Russia), which were resuspended to the concentration 1010 cells/mL in 10 mL of 0.85% NaCl solution and added to 90 mL of 2.5% SPS solution. Resulting mixture was frozen at -18°C and then lyophilized (Martin Christ Alpha 1-2 LDplus, Germany).Atomic force microscopy (AFM) images of formulated L. plantarum 8PA3 cells were acquired in air by a Solver P47H atomic force microscope (NT-MDT, Moscow, Russia).Starch swelling and dissolution was studied in simulated colonic fluid (SCF), prepared according to [3] and in distilled water (pH = 6.0) as control. Amylase from Aspergillus oryzae (A8220, Sigma) was added to the solutions to study the influence of amylase. The formulation form was examined visually during 14 h incubation time.Fluorescence microscopy images were obtained with a Leica DM6000B (Germany) fluorescent microscope using Leica FW4000 software.L. plantarum 8PA3 loaded in SPS were placed either in HCl solution (pH 2), or in 2% oxgall bile solution, or in 0.85% NaCl solution. Viability was tested after 2, 4 and 6 h incubation at 37°C by plating diluted aliquots onto MRS agar with subsequent counting of bacterial colony forming units (CFU). In addition, viability was determined using LIVE/DEAD BacLight bacterial viability kit L-7012 (Molecular Probes, Invitrogen) as described elsewhere [4]. Fluorescence in the stained samples was estimated with BD FACS Canto II (USA) flow cytometer or fluorescent microscope.Nitric oxide (NO) production was assessed with DAF-FM DA and DAA fluorescent dyes as described earlier [4]. Each experiment was performed in triplicate.

RESULTS

In the present study we studied the probiotic composition comprising of SPS and bacteria L. plantarum 8PA3. We used AFM to confirm effective fixation of the cells to carbohydrate. The compositions were found to swell quickly (~5 min) in aqueous solutions either containing amylase, or not. Tested starch formulations disintegrated during the first 5-10 min of incubation in amylase solutions whereas in amylase-free probes dissolution was less intensive (after ~30 min). Amylolysis of starch excipients was less pronounced in aqueous amylase solution than in SCF, supplemented with amylase. None of 19 studied Lactobacillus strains hydrolyzed SPS when growing on MRS agar supplemented with it. The amount of viable L. plantarum 8PA3 cells formulated with SPS was high and did not change when stored for 6 months at 4°C. The bacterial viability tests also demonstrated that after 6 h treatment with 2% bile or HCl (pH 2) L. plantarum 8PA3 exhibited increased sensitivity (viability 14% and 0.4%, respectively). However, in similar conditions no significant differences were noticed between bacterial viability obtained for formulated with starch and non-formulated bacteria. Furthermore, we showed that loading into SPS had no effect on bacterial production of nitric oxide (NO) - a pluripotent regulatory molecule in human organism.

CONCLUSIONS

Overall, the results strongly support that formulation with polymeric matrices on the basis of SPS represent an appealing technology of probiotics production. It provides slow release of bacteria in target environment and does not alter their viability and NO biosynthesis. However, SPS excipient does not preserve the bacteria from harsh conditions of upper GIT. Therefore, we conclude that for oral administration the composition should be loaded in acid-resistant capsules.

摘要

背景

益生菌是活的微生物,通常为乳酸菌或双歧杆菌,适量服用时可对宿主产生健康益处[1]。由于越来越多的证据表明其使用具有健康益处,益生菌越来越受到关注,目前已成为功能性食品行业的一个重要增长领域[2]。然而,为了发挥作用,口服益生菌应在剂型制备过程中存活下来,并通过胃肠道(GIT)的酸性环境。到达肠道后,这些微生物应能够定殖、保持活力并发挥其有益作用。在这种情况下,口服制剂必须保护益生菌免受胃酸影响,并延缓其在小肠中的释放,以便在结肠中完全释放。

目的

评估乳酸菌淀粉制剂对其在胃环境中的存活及益生菌特性的影响。

方法

从乳制品和益生菌中分离出19株属于发酵乳杆菌(14株)、植物乳杆菌(4株)和鼠李糖乳杆菌(1株)的乳酸菌菌株,用于本研究。乳酸菌在德国默克公司的德氏乳杆菌、罗格斯、夏普(MRS)肉汤中,于37°C微需氧条件下培养。在添加1%可溶性马铃薯淀粉(SPS)的MRS琼脂上培养3 - 5天的乳酸菌的淀粉酶活性,用碘试剂(0.01 M I2 - KI溶液)测定。用植物乳杆菌8PA3细菌(“干乳酸菌素”,俄罗斯彼尔姆)进行淀粉包载,将其在10 mL 0.85% NaCl溶液中重悬至浓度为1010个细胞/mL,并加入到90 mL 2.5% SPS溶液中。所得混合物在 - 18°C冷冻,然后冻干(德国马丁·克里斯Alpha 1 - 2 LDplus)。通过俄罗斯莫斯科NT - MDT公司的Solver P47H原子力显微镜在空气中获取包载植物乳杆菌8PA3细胞的原子力显微镜(AFM)图像。在按照[3]制备的模拟结肠液(SCF)和作为对照的蒸馏水(pH = 6.)中研究淀粉的膨胀和溶解。向溶液中加入米曲霉淀粉酶(A8220,西格玛)以研究淀粉酶的影响。在14小时的孵育时间内目视检查制剂形态。使用德国徕卡DM6000B荧光显微镜和徕卡FW4000软件获得荧光显微镜图像。将包载在SPS中的植物乳杆菌8PA3置于HCl溶液(pH 2)、2%牛胆汁溶液或0.85% NaCl溶液中。在37°C孵育2、4和6小时后,通过将稀释的等分试样接种到MRS琼脂上,随后计数细菌菌落形成单位(CFU)来测试活力。此外,如其他文献[4]所述,使用LIVE/DEAD BacLight细菌活力试剂盒L - 7012(分子探针公司,英杰生命技术)测定活力。用美国BD FACS Canto II流式细胞仪或荧光显微镜估计染色样品中的荧光。如前所述[4],用DAF - FM DA和DAA荧光染料评估一氧化氮(NO)的产生。每个实验重复三次。

结果

在本研究中,我们研究了由SPS和植物乳杆菌8PA3细菌组成的益生菌组合物。我们使用AFM确认细胞与碳水化合物的有效固定。发现该组合物在含有或不含淀粉酶的水溶液中迅速膨胀(约5分钟)。测试的淀粉制剂在淀粉酶溶液中孵育的前5 - 10分钟内崩解,而在无淀粉酶的样品中溶解程度较低(约30分钟后)。淀粉辅料的淀粉酶解在水性淀粉酶溶液中比在添加淀粉酶的SCF中不太明显。在添加SPS的MRS琼脂上生长时,19株研究的乳酸菌菌株均未水解SPS。用SPS包载的植物乳杆菌8PA3活细胞数量很高,在4°C储存6个月时没有变化。细菌活力测试还表明,用2%胆汁或HCl(pH 2)处理6小时后,植物乳杆菌8PA3的敏感性增加(活力分别为14%和0.4%)。然而,在类似条件下,淀粉包载细菌和未包载细菌的活力之间没有显著差异。此外,我们表明包载到SPS中对细菌产生一氧化氮(NO)没有影响,NO是人体中的一种多能调节分子。

结论

总体而言,结果有力地支持基于SPS的聚合物基质制剂是一种有吸引力的益生菌生产技术。它能在目标环境中缓慢释放细菌,且不改变其活力和NO生物合成。然而,SPS辅料不能保护细菌免受上消化道恶劣条件的影响。因此,我们得出结论,对于口服给药,该组合物应装入耐酸胶囊中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验